Ex parte CHEN et al. - Page 2



                  Appeal No. 1997-4277                                                                                      
                  Application No. 08/290,038                                                                                

                             cells formed by viable normal human fetal bone fragments and normal                            
                             human fetal spleen grown in juxtaposition.                                                     
                         5. A method for producing a chimeric mouse capable of long term                                    
                             production, for greater than twenty weeks, of human myeloid cells, B-cells                     
                             and lymphoid progenitor cells, said method comprising:                                         
                                implanting viable normal human fetal spleen and normal human fetal                          
                             bone fragments in juxtaposition at a sub-cutaneous site in an                                  
                             immunocompromised mouse host lacking functional syngeneic B- and T-                            
                             cells due to a genetic defect that results in an inability to undergo                          
                             germline DNA rearrangement at the loci encoding immunoglobulins and                            
                             T-cell antigen receptors;                                                                      
                                whereby said tissue forms a hybrid tissue providing long-term                               
                             production, for greater than twenty weeks, of human myeloid cells, B-                          
                             lineage cells and lymphoid progenitor cells.                                                   
                         18. A method for determining the repertoire of lineages that are able to                           
                              develop from a particular human hematopoietic progenitor cell type, said                      
                              method comprising:                                                                            
                                implanting viable normal human fetal spleen, normal human fetal bone                        
                              fragments and normal human fetal thymus tissue in juxtaposition at a                          
                              subcutaneous site in an immunocompromised mouse host lacking                                  
                              functional syngeneic B- and T-cells due to a genetic defect that results in                   
                              an inability to undergo germline DNA rearrangement at the loci encoding                       
                              immunoglobulins and T-cell antigen receptors;                                                 
                                irradiating said hybrid tissue;                                                             
                                injected HLA mismatched human hematopoietic progenitor cells into                           
                              the cavity of said human bone;                                                                
                                maintaining said host, whereby said tissue forms a hybrid tissue                            
                              allowing long-term production, of at least twenty weeks, of human                             
                              myeloid cells, B-cells and T-cells; and                                                       
                                determining the repertoire of lineages of hematopoietic cells that                          
                              develop having the HLA type of said progenitor cells.1                                        





                                                                                                                            
                  1 We note appellants’ Brief contains the following typographical error “determining                       
                  … that having” should be “determining … that develop having.”  Compare claim 18,                          
                  Paper No. 7, received January 11, 1996.                                                                   

                                                             2                                                              



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007